Rare Disease Report

An Overview of Neuroendocrine Tumors

MAY 30, 2015
James Radke, PhD



Neuroendocrine tumors are a rare and diverse group of carcinoid or pancreatic tumors that secrete abnormally high quantities of hormones. Due to the absence of specific symptoms, the disease may not be diagnosed quickly. Once diagnosed however, treatment options are available.

Lanreotide is an injectable somatostatin analog that inhibits the secretion of several endocrine, exocrine and paracrine functions. It was approved for the treatment of NETs in December 2014.

In this interview, Matthew Kulke, MD, of the Dana Farber Cancer Institute provides an overview of NETs.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.